Various tech companies are investing billions of dollars in developing contact tracing apps and surveillance drones using big data and artificial intelligence
Fremont, CA: As the COVID-19 pandemic continues to spread havoc across the globe, big data has emerged as one of the leading disruptive technologies that can help limit the spread of the virus. During these testing times, drug discovery, surveillance, and tracking and tracing technologies have gained significant importance in developing platforms that can help the human race deal with this crisis. Various tech companies are investing billions of dollars in developing contact tracing apps and surveillance drones using big data and artificial intelligence. While these technologies show a lot of promise in the fight against the disease, there are also a lot of questions being asked about the same. Such as the high rates of false-positive cases and the use of these technologies in a post-COVID-19 world. Despite these concerns, tech giants like Google and Apple are working in collaboration with various governments to help them with contact tracing to tackle the virus.
Experts believe big data could be one of the prime assets in the war against the disease, with various uses for big data and big data analytics like surveillance in smart cities, contact tracing, and vaccine development. Big data in smart cities can be easily deployed to identify the population's compliance with social distancing measures. Surveillance data from cameras can be used to identify pedestrian traffic in different regions. Big data analytics can be especially useful in concentrating efforts on areas where social distancing and safety measures in sparsely followed. It can also help establish a relation between the rate of the spread of the virus and compliance with authorities, helping to understand the importance of social distancing better, and reducing the impact of the virus.
The combination of artificial intelligence and big data platforms can come in handy in digging through years of data to identify possible drugs that have been previously approved to treat similar viruses. Combining these technologies can help identify new molecules using this database to help us develop a vaccine quicker. The availability of such advanced technology for drug discovery is one of the reasons it is not as fatal as it would have been in the past. If leveraged correctly, these technologies can help medical experts arrive at a vaccine at the earliest.